Literature DB >> 27083386

New models of hematogenous ovarian cancer metastasis demonstrate preferential spread to the ovary and a requirement for the ovary for abdominal dissemination.

Lan G Coffman1, Daniela Burgos-Ojeda2, Rong Wu3, Kathleen Cho3, Shoumei Bai2, Ronald J Buckanovich4.   

Abstract

Emerging evidence suggest that many high-grade serous "ovarian" cancers (HGSOC) start in the fallopian tube. Cancer cells are then recruited to the ovary and then spread diffusely through the abdomen. The mechanism of ovarian cancer spread was thought to be largely due to direct shedding of tumor cells into the peritoneal cavity with vascular spread being of limited importance. Recent work challenges this dogma, suggesting hematogenous spread of ovarian cancer may play a larger role in ovarian cancer cell metastasis than previously thought. One reason the role of vascular spread of ovarian cancer has not been fully elucidated is the lack of easily accessible models of vascular ovarian cancer metastasis. Here, we present 3 metastatic models of ovarian cancer which confirm the ability of ovarian cancer to hematogenously spread. Strikingly, we observe a high rate of metastasis to the ovary with the development of ascites in these models. Interestingly, oophorectomy resulted in a complete loss of peritoneal metastases and ascites. Taken together, our data indicate that hematogenously disseminated HGSOC cells have a unique tropism for the ovary and that hematogenous spread in ovarian cancer may be more common than appreciated. Furthermore, our studies support a critical role for the ovary in promoting HGSOC cell metastasis to the abdomen. The models developed here represent important new tools to evaluate both the mechanism of cancer cell recruitment to the ovary and understand and target key steps in ovarian cancer metastasis.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27083386      PMCID: PMC5003680          DOI: 10.1016/j.trsl.2016.03.016

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  37 in total

1.  Establishment of an in vivo model for pediatric Ewing tumors by transplantation into NOD/scid mice.

Authors:  J Vormoor; G Baersch; S Decker; M Hotfilder; K L Schäfer; L Pelken; C Rübe; F Van Valen; H Jürgens; B Dockhorn-Dworniczak
Journal:  Pediatr Res       Date:  2001-03       Impact factor: 3.756

2.  Ovarian cancer development and metastasis.

Authors:  Ernst Lengyel
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

3.  A murine model for bone marrow metastasis established by an i.v. injection of C-1300 neuroblastoma in A/J mice.

Authors:  M Iwakawa; K Ando; H Ohkawa; S Koike; Y J Chen
Journal:  Clin Exp Metastasis       Date:  1994-05       Impact factor: 5.150

Review 4.  Modeling metastasis in vivo.

Authors:  Chand Khanna; Kent Hunter
Journal:  Carcinogenesis       Date:  2004-09-09       Impact factor: 4.944

5.  Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways.

Authors:  Rong Wu; Neali Hendrix-Lucas; Rork Kuick; Yali Zhai; Donald R Schwartz; Aytekin Akyol; Samir Hanash; David E Misek; Hidetaka Katabuchi; Bart O Williams; Eric R Fearon; Kathleen R Cho
Journal:  Cancer Cell       Date:  2007-04       Impact factor: 31.743

6.  Bilateral ovarian carcinoma: cytogenetic evidence of unicentric origin.

Authors:  T Pejovic; S Heim; N Mandahl; B Elmfors; S Furgyik; U M Flodérus; G Helm; H Willén; F Mitelman
Journal:  Int J Cancer       Date:  1991-02-01       Impact factor: 7.396

7.  Metastasis of hormone-independent breast cancer to lung and bone is decreased by alpha-difluoromethylornithine treatment.

Authors:  Monica M Richert; Pushkar A Phadke; Gail Matters; Douglas J DiGirolamo; Sharlene Washington; Laurence M Demers; Judith S Bond; Andrea Manni; Danny R Welch
Journal:  Breast Cancer Res       Date:  2005-08-09       Impact factor: 6.466

8.  Clinical characteristics of metastatic tumors to the ovaries.

Authors:  Sung-Jong Lee; Jeong-Hoon Bae; A-Won Lee; Seo-Yun Tong; Yong-Gyu Park; Jong-Sup Park
Journal:  J Korean Med Sci       Date:  2009-02-28       Impact factor: 2.153

9.  Tumor spreading to the contralateral ovary in bilateral ovarian carcinoma is a late event in clonal evolution.

Authors:  Francesca Micci; Lisbeth Haugom; Terje Ahlquist; Vera M Abeler; Claes G Trope; Ragnhild A Lothe; Sverre Heim
Journal:  J Oncol       Date:  2009-09-15       Impact factor: 4.375

10.  Isolated ovarian metastasis of gastric cancer: Krukenberg tumor.

Authors:  Ummugul Uyeturk; Serife Hulya Arslan; Oznur Bal; Ulku Yalcintas Arslan; Omur Berna Cakmak Oksuzoglu
Journal:  Contemp Oncol (Pozn)       Date:  2013-12-19
View more
  35 in total

1.  PTEN loss in the fallopian tube induces hyperplasia and ovarian tumor formation.

Authors:  Angela Russo; Austin A Czarnecki; Matthew Dean; Dimple A Modi; Daniel D Lantvit; Laura Hardy; Seth Baligod; David A Davis; Jian-Jun Wei; Joanna E Burdette
Journal:  Oncogene       Date:  2018-01-25       Impact factor: 9.867

2.  Host Wnt5a Potentiates Microenvironmental Regulation of Ovarian Cancer Metastasis.

Authors:  Marwa Asem; Allison M Young; Carlysa Oyama; Alejandro Claure De La Zerda; Yueying Liu; Jing Yang; Tyvette S Hilliard; Jeffery Johnson; Elizabeth I Harper; Ian Guldner; Siyuan Zhang; Toni Page-Mayberry; William J Kaliney; M Sharon Stack
Journal:  Cancer Res       Date:  2020-01-13       Impact factor: 12.701

3.  Exposure of the extracellular matrix and colonization of the ovary in metastasis of fallopian-tube-derived cancer.

Authors:  Matthew Dean; Vivian Jin; Angela Russo; Daniel D Lantvit; Joanna E Burdette
Journal:  Carcinogenesis       Date:  2019-03-12       Impact factor: 4.944

4.  Epigenomic Reprogramming toward Mesenchymal-Epithelial Transition in Ovarian-Cancer-Associated Mesenchymal Stem Cells Drives Metastasis.

Authors:  Huihui Fan; Huda I Atiya; Yeh Wang; Thomas R Pisanic; Tza-Huei Wang; Ie-Ming Shih; Kelly K Foy; Leonard Frisbie; Ronald J Buckanovich; Alison A Chomiak; Rochelle L Tiedemann; Scott B Rothbart; Chelsea Chandler; Hui Shen; Lan G Coffman
Journal:  Cell Rep       Date:  2020-12-08       Impact factor: 9.423

5.  Post-translational modification of the membrane type 1 matrix metalloproteinase (MT1-MMP) cytoplasmic tail impacts ovarian cancer multicellular aggregate dynamics.

Authors:  Jing Yang; William C Kasberg; Angela Celo; Zhong Liang; Kristal Quispe; M Sharon Stack
Journal:  J Biol Chem       Date:  2017-06-27       Impact factor: 5.157

6.  Activin A stimulates migration of the fallopian tube epithelium, an origin of high-grade serous ovarian cancer, through non-canonical signaling.

Authors:  Matthew Dean; David A Davis; Joanna E Burdette
Journal:  Cancer Lett       Date:  2017-01-20       Impact factor: 8.679

7.  EGFL6 Regulates the Asymmetric Division, Maintenance, and Metastasis of ALDH+ Ovarian Cancer Cells.

Authors:  Shoumei Bai; Patrick Ingram; Yu-Chih Chen; Ning Deng; Alex Pearson; Yashar S Niknafs; Patrick O'Hayer; Yun Wang; Zhong-Yin Zhang; Elisa Boscolo; Joyce Bischoff; Euisik Yoon; Ronald J Buckanovich
Journal:  Cancer Res       Date:  2016-11-01       Impact factor: 12.701

Review 8.  Fallopian tube initiation of high grade serous ovarian cancer and ovarian metastasis: Mechanisms and therapeutic implications.

Authors:  Tova M Bergsten; Joanna E Burdette; Matthew Dean
Journal:  Cancer Lett       Date:  2020-02-15       Impact factor: 8.679

9.  In vivo selection of highly metastatic human ovarian cancer sublines reveals role for AMIGO2 in intra-peritoneal metastatic regulation.

Authors:  Yueying Liu; Jing Yang; Zonggao Shi; Xuejuan Tan; Norman Jin; Catlin O'Brien; Connor Ott; Anna Grisoli; Eric Lee; Kelly Volk; Meghan Conroy; Emily Franz; Annamarie Bryant; Leigh Campbell; Brian Crowley; Stephen Grisoli; Aris T Alexandrou; Chunyan Li; Elizabeth I Harper; Marwa Asem; Jeff Johnson; Annemarie Leonard; Katie Santanello; Ashley Klein; Qingfei Wang; Siyuan Zhang; Tyvette S Hilliard; M Sharon Stack
Journal:  Cancer Lett       Date:  2021-01-30       Impact factor: 8.679

Review 10.  Models for measuring metabolic chemical changes in the metastasis of high grade serous ovarian cancer: fallopian tube, ovary, and omentum.

Authors:  Hannah Lusk; Joanna E Burdette; Laura M Sanchez
Journal:  Mol Omics       Date:  2021-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.